Cancer Cachexia Market Size, Share, Growth Analysis, By Product(Progestogens, Corticosteroids, Combination Therapies, and Others), By Distribution Channels(Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Mechanism of Action(Appetite Stimulators and Weight Loss Stabilizers), By Region - Industry Forecast 2024-2031

Drivers

The Chemical Potential in Pipeline to Propel Growth

• Current treatment options for cachexia in cancer patients are limited to drugs such as progestogens, corticosteroids, and others. These drugs have shown efficacy in the treatment of cancer-induced cachexia, although there are clinical differences in treatment outcomes and no drug candidates are currently approved specifically for this condition. This increases the gap in therapeutic options, which market players are aiming to fill through R&D and the introduction of new drugs in the global market.

Rise in the Incidence of Cancer

• The growth in the global market will be driven by the increasing incidence of cancer worldwide, as well as increasing funding for R&D to develop new breakthrough therapeutics with certain mechanisms of action. The market growth is favored by increasing focus on cancer palliative care with increasing cancer incidence. Treatment of cancer cachexia includes stimulants and medications. There are several urinary tract drugs in late-stage clinical trials, for the treatment of cancer cachexia, which are expected to be commercialized in the next two to three years. This is also expected to drive market growth.

Restraints

High Costs Associated with Treatment and Aggressive Government Programs to Prevent Development

• Despite the increasing prevalence of cancer cachexia across the globe, certain factors are restraining the growth of the overall market. Includes high costs associated with cancer and its adjuvant treatments, low drug reimbursement in developing countries. Estimated costs associated with the treatment of cancer patients with cachexia are slightly higher than non-cachexia cancer patients. Thus, the associated high out-of-pocket costs with cancer-induced cachexia and lack of approved products to treat the disease would contribute to the gradual growth of this market during the predicted period.

Limited Understanding of Mechanisms

• The specific mechanisms underlying cancer cachexia are complex and poorly understood. This lack of clarity hinders the development of targeted treatments and interventions, making it difficult to manage the situation effectively. Cancer cachexia can result from a variety of underlying cancers, each with unique characteristics. The heterogeneity of cancer types and cachexia presents challenges in developing universal therapeutic strategies.